You just read:

Canadians now have publicly funded access to CIMZIA® (certolizumab pegol) Autoinjector for the Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis indications

News provided by

UCB Canada Inc.

Sep 26, 2018, 06:00 ET